This content is from: United States FDA fixes for generic delays may not work, say patent counsel Counsel that represent generic pharma companies say a letter from the FDA to the USPTO highlights important patent issues but may not fix them By Rani Mehta September 24 2021
This content is from: United States Corner office podcast: Scott Frank on leading AT&T IP in 2021 By Patrick Wingrove September 24 2021
This content is from: International NFTs: why IP counsel don’t see revolution, for now By Sukanya Sarkar September 23 2021
This content is from: China IPO Annual Meeting: Counsel dive into anti-anti-suit injunctions By Patrick Wingrove September 22 2021
This content is from: International IPO Annual Meeting: How counsel transform operations with data By Patrick Wingrove September 22 2021
This content is from: United States A guide to trade secrets updates in four IP hubs By Alastair Shaw & Anna-Katharina Friese & Joel Smith & Joseph Raffetto & Ruud van der Velden & Tej Singh September 22 2021
This content is from: United States IPO Annual Meeting: Speakers set out AI healthcare challenges By Patrick Wingrove September 21 2021
This content is from: United States Why ex-parte reexams are picking up at the USPTO Counsel at Cisco, Unified Patents and elsewhere unpick data that shows how patent challengers are turning to old procedures, often after discretionary denials By Patrick Wingrove September 20 2021
